ABIVAX Société Anonyme (EPA:ABVX)
77.50
+1.10 (1.44%)
Sep 10, 2025, 2:02 PM CET
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 4.01M EUR in the half year ending December 31, 2024, with 78.20% growth. This brings the company's revenue in the last twelve months to 10.59M, up 128.98% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.
Revenue (ttm)
10.59M
Revenue Growth
+128.98%
P/S Ratio
958.63
Revenue / Employee
87.29K
Employees
69
Market Cap
5.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
Dec 31, 2020 | 14.00K | 21.00K | -300.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
Virbac | 1.40B |
emeis Société anonyme | 5.64B |
ABIVAX Société Anonyme News
- 1 day ago - BTIG Reiterates Buy Rating on Abivax (ABVX) with $112 Price Target | ABVX Stock News - GuruFocus
- 1 day ago - Abivax SA (ABVX) Reports First Half 2025 Financial Results | ABVX stock news - GuruFocus
- 1 day ago - Abivax Presents First Half 2025 Financial Results - GlobeNewsWire
- 4 days ago - Abivax (ABVX) Gains on Takeover Speculation - GuruFocus
- 4 days ago - Abivax jumps amid takeover speculation - Seeking Alpha
- 9 days ago - Abivax (ABVX) Surges Following Positive Trial Data, Boosts Hedge Funds - GuruFocus
- 10 days ago - Abivax’s 580% surge hands biotech hedge funds a rare 2025 win - Seeking Alpha
- 11 days ago - How Hedge Funds Won Big on an Obscure Drugmaker - WSJ